2,838
Views
4
CrossRef citations to date
0
Altmetric
Oncology

Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy

, , , &
Pages 1339-1349 | Received 16 Sep 2021, Accepted 21 Apr 2022, Published online: 10 May 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.